Medicare can cover Zepbound for sleep apnea, creating a significant opportunity for Eli Lilly

by | Jan 9, 2025 | Stock Market

Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment costs about $1,000 a month without insurance.

Article Attribution | Read More at Article Source